Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EVGN NYSE:UAN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVGNEvogene$0.43-3.2%$0.66$0.37▼$1.50$3.71M1.35783,781 shs51,652 shsUANCVR Partners$111.20-0.3%$121.69$84.13▼$139.50$1.18B0.1467,986 shs9,404 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVGNEvogene+1.74%-10.61%-37.74%-45.75%-65.71%UANCVR Partners-0.60%+1.14%-7.96%-9.68%+25.53%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVGNEvogene$0.43-3.2%$0.66$0.37▼$1.50$3.71M1.35783,781 shs51,652 shsUANCVR Partners$111.20-0.3%$121.69$84.13▼$139.50$1.18B0.1467,986 shs9,404 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVGNEvogene+1.74%-10.61%-37.74%-45.75%-65.71%UANCVR Partners-0.60%+1.14%-7.96%-9.68%+25.53%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVGNEvogene 2.50Moderate BuyN/AN/AUANCVR Partners 3.00BuyN/AN/ACurrent Analyst Ratings BreakdownLatest UAN and EVGN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026UANCVR Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Buy (B)(Data available from 7/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVGNEvogene$3.85M0.96N/AN/A$1.37 per share0.31UANCVR Partners$643.22M1.83$17.02 per share6.55$25.14 per share4.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVGNEvogene-$8.48M-$1.39N/AN/AN/A-638.12%-158.82%-80.37%8/26/2026 (Estimated)UANCVR Partners$98.66M$11.509.70N/AN/A18.89%40.08%12.08%7/29/2026 (Estimated)Latest UAN and EVGN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/16/2026Q1 2026EVGNEvogene-$0.27-$0.60-$0.33-$0.60$0.35 million$0.33 million4/29/2026Q1 2026UANCVR PartnersN/A$4.72N/A$4.72N/A$180.05 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthEVGNEvogeneN/AN/AN/AN/AN/AUANCVR Partners$16.0014.35%N/A139.13%1 YearsLatest UAN and EVGN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2026UANCVR Partnersquarterly$4.0012.19%5/11/20265/11/20265/18/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEVGNEvogeneN/A2.792.76UANCVR Partners1.832.751.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVGNEvogene10.40%UANCVR Partners43.83%Insider OwnershipCompanyInsider OwnershipEVGNEvogene7.40%UANCVR Partners0.36%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEVGNEvogene1408.72 million8.07 millionNo DataUANCVR Partners30010.57 million10.53 millionOptionableUAN and EVGN HeadlinesRecent News About These CompaniesCVR Energy, CVR Partners CFO Neumann to become president/CEO; Pytosh departsJune 22, 2026 | msn.comCVR Partners LP (UAN): Carl C. Icahn Reiterates Bullish StanceMay 14, 2026 | finance.yahoo.comIs CVR Partners (UAN) Offering Value After 76.8% One‑Year Share Price Gain?May 6, 2026 | finance.yahoo.comA Look At CVR Partners (UAN) Valuation After Strong Q1 Results And Ammonia Expansion PlansMay 5, 2026 | finance.yahoo.comThe Bull Case For CVR Partners (UAN) Could Change Following Strong Q1 Payout And Utilization OutlookMay 5, 2026 | finance.yahoo.comCVR Partners, LP (NYSE:UAN) Q1 2026 Earnings Call TranscriptMay 2, 2026 | insidermonkey.comCvr Partners (UAN) Q1 2026 Earnings TranscriptMay 2, 2026 | fool.comCvr partners expects Q2 2026 ammonia utilization at 95%-100% while projecting $60M-$75M in 2026 capexMay 2, 2026 | seekingalpha.comCVR Partners, LP Common Units (UAN) Q1 2026 Earnings Call Prepared Remarks TranscriptApril 30, 2026 | seekingalpha.comCVR Partners Reports First Quarter 2026 ResultsApril 29, 2026 | businesswire.comMispriced CVR Partners Looks Ready To GrowApril 25, 2026 | seekingalpha.comTop 3 fertilizer stocks to buy in AprilApril 17, 2026 | finbold.comFCVR Partners Posts Q4 Loss But Maintains 2025 PayoutsMarch 31, 2026 | theglobeandmail.comCF, UAN stocks rally on supply shock due to Middle East disruptions – here’s why analysts see further upsideMarch 27, 2026 | msn.comIran Conflict Tightens Fertilizer Supply And Lifts CVR Partners OutlookMarch 18, 2026 | finance.yahoo.comCVR Partners (NYSE:UAN) Reaches New 52-Week High – Here’s WhyMarch 8, 2026 | defenseworld.netDCVR Partners Faces NYSE Non‑Compliance After Director’s DeathMarch 3, 2026 | tipranks.comCVR Partners, LP (NYSE:UAN) Q4 2025 earnings call transcriptFebruary 20, 2026 | msn.comCVR Partners targets 95%-100% ammonia utilization in Q1 2026 as reliability projects advanceFebruary 20, 2026 | seekingalpha.comCVR Partners LP (UAN) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...February 20, 2026 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUAN and EVGN Company DescriptionsEvogene NASDAQ:EVGN$0.42 -0.01 (-3.17%) As of 11:08 AM Eastern This is a fair market value price provided by Massive. Learn more.Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.CVR Partners NYSE:UAN$111.20 -0.28 (-0.25%) As of 11:13 AM Eastern This is a fair market value price provided by Massive. Learn more.CVR Partners, LP, together with its subsidiaries, engages in the production and sale of nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was incorporated in 2007 and is based in Sugar Land, Texas. CVR Partners, LP is a subsidiary of CVR Energy, Inc. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Charts That Could Change the Course of Summer Trading Short Squeeze Alert—Moderna Stock Surges on New Strategy These 3 Dividend Stocks Could Boost Your Income This July The Quantum Bubble Is Real Enough to Take Seriously Amazon Could Be About to Reap the Rewards of a Software Spending Boom Could Apple's China Play Be the Answer to Its Memory Pressure Problem? Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks Why Wall Street Still Sees Massive Upside for AeroVironment Stock Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
